Hyundai Bioscience announced positive phase 2 clinical study results of the global blockbuster candidate for the COVID-19 antiviral drug ...Middle East

- Hyundai Bioscience announcing the receipt of the phase 2 clinical study report of XaftyTM and its plans for the emergency use authorization - Planning fast track process in oversea countries to enter the global market SEOUL, South Korea, May 2, 2023 /PRNewswire/ -- Hyundai Bioscience...

Hence then, the article about hyundai bioscience announced positive phase 2 clinical study results of the global blockbuster candidate for the covid 19 antiviral drug was published today ( Wednesday 03/05/2023 - 05:53 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Hyundai Bioscience announced positive phase 2 clinical study results of the global blockbuster candidate for the COVID-19 antiviral drug )

Also on site :

• Person falls to death on Boylston Street on New Year’s Eve
• Suspected mountain lion attack in Colorado mountains under investigation
• Skanska signs additional contract with existing client to build a data center in USA for USD 228M, about SEK 2.2 billion